Sunshine Capital Stock from 2010 to 2025

SBFMW Stock

USD 0.24 0.04 20.00%

Sunshine Biopharma Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 24.8 K in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

26.1 K

Current Value

24.8 K

Quarterly Volatility

98.5 K

Credit Downgrade

Yuan Drop

Covid

Check Sunshine Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sunshine Biopharma's main balance sheet or income statement drivers, such as Interest Expense of 148.9 K, Other Operating Expenses of 34.9 M or Total Operating Expenses of 15.8 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0 or PTB Ratio of 0.34. Sunshine financial statements analysis is a perfect complement when working with Sunshine Biopharma Valuation or Volatility modules.

Check out the analysis of Sunshine Biopharma Correlation against competitors.

For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide.

Latest Sunshine Biopharma's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Sunshine Biopharma Warrant over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Sunshine Biopharma's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sunshine Biopharma's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Sunshine Capital Stock Regression Statistics

	Arithmetic Mean	122,421
	Geometric Mean	92,136
	Coefficient Of Variation	80.48
	Mean Deviation	55,384
	Median	135,652
	Standard Deviation	98,526
	Sample Variance	9.7B
	Range	422.8K
	R-Value	(0.29)
	Mean Square Error	9.5B
	R-Squared	0.08
	Significance	0.27
	Slope	(6,024)
	Total Sum of Squares	145.6B

Sunshine Capital Stock History

	2025	24.8 K
	2024	26.1 K
	2023	29 K
	2022	23.6 K
	2021	102.6 K
	2020	446.4 K
	2019	85.3 K

Other Fundumenentals of Sunshine Biopharma

Issuance Of Capital Stock

Sunshine Biopharma Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Intangible Assets	Net Tangible Assets	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Good Will	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Investments
Total Assets		1.0	-0.98	-0.94	1.0	0.98	1.0	-0.31	0.21	0.99	0.78	0.78	-0.78	0.61	0.77	-0.68	1.0	0.9	-0.58	1.0	-0.68
Total Stockholder Equity	1.0		-0.98	-0.92	1.0	0.97	1.0	-0.31	0.17	0.99	0.78	0.78	-0.75	0.58	0.75	-0.68	1.0	0.88	-0.6	1.0	-0.68
Net Debt	-0.98	-0.98		0.93	-0.98	-0.96	-0.98	0.32	-0.28	-0.95	-0.73	-0.77	0.75	-0.6	-0.77	0.53	-0.99	-0.86	0.6	-0.98	0.53
Retained Earnings	-0.94	-0.92	0.93		-0.93	-0.97	-0.94	0.24	-0.36	-0.91	-0.81	-0.81	0.91	-0.78	-0.9	0.52	-0.93	-0.93	0.49	-0.94	0.52
Accounts Payable	1.0	1.0	-0.98	-0.93		0.98	1.0	-0.31	0.2	0.99	0.78	0.77	-0.77	0.6	0.75	-0.67	1.0	0.88	-0.58	1.0	-0.67
Total Liab	0.98	0.97	-0.96	-0.97	0.98		0.98	-0.28	0.35	0.95	0.75	0.78	-0.85	0.7	0.82	-0.63	0.98	0.91	-0.49	0.98	-0.63
Total Current Assets	1.0	1.0	-0.98	-0.94	1.0	0.98		-0.31	0.22	0.98	0.77	0.78	-0.78	0.62	0.77	-0.67	1.0	0.9	-0.57	1.0	-0.67
Common Stock	-0.31	-0.31	0.32	0.24	-0.31	-0.28	-0.31		-0.06	-0.3	-0.12	-0.38	0.36	-0.31	-0.36	0.18	-0.3	-0.36	0.31	-0.31	0.18
Short Term Debt	0.21	0.17	-0.28	-0.36	0.2	0.35	0.22	-0.06		0.06	-0.14	0.3	-0.41	0.41	0.43	0.21	0.25	0.31	-0.08	0.21	0.21
Net Receivables	0.99	0.99	-0.95	-0.91	0.99	0.95	0.98	-0.3	0.06		0.83	0.76	-0.75	0.57	0.73	-0.73	0.98	0.88	-0.57	0.99	-0.73
Intangible Assets	0.78	0.78	-0.73	-0.81	0.78	0.75	0.77	-0.12	-0.14	0.83		0.63	-0.69	0.64	0.75	-0.5	0.75	0.73	-0.41	0.78	-0.5
Net Tangible Assets	0.78	0.78	-0.77	-0.81	0.77	0.78	0.78	-0.38	0.3	0.76	0.63		-0.7	0.46	0.73	-0.48	0.78	0.87	-0.72	0.79	-0.48
Property Plant Equipment	-0.78	-0.75	0.75	0.91	-0.77	-0.85	-0.78	0.36	-0.41	-0.75	-0.69	-0.7		-0.92	-0.94	0.48	-0.77	-0.9	0.26	-0.79	0.48
Current Deferred Revenue	0.61	0.58	-0.6	-0.78	0.6	0.7	0.62	-0.31	0.41	0.57	0.64	0.46	-0.92		0.92	-0.25	0.6	0.73	-0.13	0.63	-0.25
Long Term Debt	0.77	0.75	-0.77	-0.9	0.75	0.82	0.77	-0.36	0.43	0.73	0.75	0.73	-0.94	0.92		-0.33	0.76	0.9	-0.39	0.79	-0.33
Good Will	-0.68	-0.68	0.53	0.52	-0.67	-0.63	-0.67	0.18	0.21	-0.73	-0.5	-0.48	0.48	-0.25	-0.33		-0.65	-0.62	0.36	-0.68	1.0
Net Invested Capital	1.0	1.0	-0.99	-0.93	1.0	0.98	1.0	-0.3	0.25	0.98	0.75	0.78	-0.77	0.6	0.76	-0.65		0.89	-0.58	1.0	-0.65
Short Long Term Debt	0.9	0.88	-0.86	-0.93	0.88	0.91	0.9	-0.36	0.31	0.88	0.73	0.87	-0.9	0.73	0.9	-0.62	0.89		-0.54	0.91	-0.62
Capital Stock	-0.58	-0.6	0.6	0.49	-0.58	-0.49	-0.57	0.31	-0.08	-0.57	-0.41	-0.72	0.26	-0.13	-0.39	0.36	-0.58	-0.54		-0.58	0.36
Net Working Capital	1.0	1.0	-0.98	-0.94	1.0	0.98	1.0	-0.31	0.21	0.99	0.78	0.79	-0.79	0.63	0.79	-0.68	1.0	0.91	-0.58		-0.68
Short Term Investments	-0.68	-0.68	0.53	0.52	-0.67	-0.63	-0.67	0.18	0.21	-0.73	-0.5	-0.48	0.48	-0.25	-0.33	1.0	-0.65	-0.62	0.36	-0.68

Click cells to compare fundamentals

About Sunshine Biopharma Financial Statements

Sunshine Biopharma investors use historical fundamental indicators, such as Sunshine Biopharma's Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sunshine Biopharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	26.1 K	24.8 K
Issuance Of Capital Stock	-10.5 M	-9.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Sunshine Stock Analysis

When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sunshine Capital Stock from 2010 to 2025

Latest Sunshine Biopharma's Capital Stock Growth Pattern

Sunshine Capital Stock Regression Statistics

Sunshine Capital Stock History

Other Fundumenentals of Sunshine Biopharma

Sunshine Biopharma Capital Stock component correlations

About Sunshine Biopharma Financial Statements

Also Currently Popular

Additional Tools for Sunshine Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY